why am.i not losing weight on semaglutide 10 Reasons You Are GLP-1s semaglutide and not losing weight

Retrieved 16 January 2023

WE CHECKED IN WITH BLUE CROSS BLUE SHIELD ABOUT INSURANCE COVERAGE: Blue Cross and Blue Shield of Alabama does cover GLP-1 drugs (glucagon-like-peptide 1 agonists) that are FDA approved for treating type 2 diabetes such as Ozempic, Trulicity, and others

FDA review takes 1012 months under standard review, or approximately 6 months if priority review is granted, putting approval between Q3 2027 and Q1Q2 2028, with commercial launch following 13 months later

For instance, while GLP-1 agonists are primarily metabolised by the kidneys and have a low potential for significant drug-drug interactions, it is still important to monitor patients closely when combining therapies

People with a personal or family history of medullary thyroid carcinoma or MEN2 syndrome should not take it

Novo Nordisk sued in February, the case drew a Department of Justice referral, and Hims restricted its compounded products only to those who medically need them, and pivoted to branded GLP-1s